[1] 陈伟伟,高润森,刘力生,等. 《中国心血管病报告2014》概要
[J].中国循环杂志,2015,7(30):205.
[2] Kotseva K, Wood D, De Backer G, et al. Cardiovascular pre?
vention guidelines in daily practice: a comparison of EU ?
ROASPIRE I, II, and III surveys in eight European countries
[J]. Lancet, 2009,373(9667):929-940.
[3] Franklin BA, Trivax JE, Vanhecke TE. New insights in pre?
ventive cardiology and cardiac rehabilitation [J]. Curr Opin Car?
diol, 2008,23(5):477-486.
[4] Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially
modifiable risk factors associated with myocardial infarction in
52 countries (the INTERHEART study): case- control study
[J]. Lancet, 2004,364(9438):937-952.
[5] Schoenenberger AW, Radovanovic D, Stauffer JC, et al.
Acute coronary syndromes in young patients: presentation,
treatment and outcome [J]. Int J Cardiol, 2011,148(3):300-
304.
[6] Reibis R, Treszi A, Weqscheider K, et al. Disparity in risk fac?
tor pattern in premature versus late- onset coronary artery dis?
ease: a survey of 15,381 patients [J]. Vasc Health Risk Manag,
2012(8):473-481.
[7] Gordon T, Castelli WP, Hjortland MC, et al. Predicting coro?
nary heart disease in middle- aged and older persons: the
Framingham study [J]. JAMA, 1977,238:497-499.
[8] Schoenenberger AW, Radovanovic D, Stauffer JC, et al.
Acute coronary syndromes in young patients: presentation,
treatment and outcome [J]. Int J Cardiol, 2011,148(3):300-
304.
[9] Sargent JD, Demidenko E, Malenka DJ, et al. Smoking re?
strictions and hospitalization for acute coronary events in Ger?
many [J]. Clin Res Cardiol, 2012,101(3):227-235.
[10] Berenson GS, Wattigney WA, Tracy RE, et al. Atherosclero?
sis of the aorta and coronary arteries and cardiovascular risk fac?
tors in persons aged 6 to 30 years and studied at necropsy (the
Bogalusa heart study) [J]. Am J Cardiol, 1992(70):851-858.
[11] Pathobiological Determinants of Atherosclerosis in Youth
(PDAY) Research Group. Natural history of aortic and coro?
nary atherosclerotic lesions in youth. Findings from the PDAY
study [J]. Arterioscler Thromb, 1993(13):1291-1298.
[12] Thompson GR, Dean J, Wilson PWF. Dyslipidaemia in clini?
cal practice [M]. London: Martin Dunitz, 2002.
[13] Andresdottir MB, Sigurdsson G, Sigvaldason H, et al. Fifteen
percent of myocardial infarctions and coronary revasculariza?
tions explained by family history unrelated to conventional risk
factors: the Reykjavik Cohort Study [J]. Eur Heart, 2002,23
(21):1655-1663.
[14] Isordia-Salas I, Trejo-Aguilar A, Valadés-Mejía MG, et al.
C677T polymorphism of the 5,10 MTHFR gene in young
Mexican subjects with ST- elevation myocardial infarction [J].
Arch Med Res, 2010(41):246-250.
[15] Motovska Z, Kvasnicka J, Widimsky P, et al. Platelet glyco?
protein GP VI 13254C allele is an independent risk factor of
premature myocardial infarction [J]. Thromb Res, 2010(125):
e61-64.
[16] Isordia-Salas I, Lea?os-Miranda A, Sainz IM, et al. Associ?
ation of the plasminogen activator inhibitor- 1 gene 4G/5G
polymorphism with ST elevation acute myocardial infarction in
young patients [J]. Rev Esp Cardiol, 2009(62):365-372.
[17] Calvier L, Miana M. Galectin- 3 mediates aldosterone- in?
duced vascular fibrosis [J]. Arterioscler Thromb Vasc Biol,
2013,33(1):67-75.
[18] de Boer RA, van Veldhuisen DJ, Gansevoort RT, et al. The fi?
brosis marker galectin- 3 and outcome in the general population
[J]. J Intern Med, 2012,272(1):55-64.
[19] Falcone C, Lucibello S, Mazzucchelli I, et al. Galectin-3 plas?
ma levels and coronary artery disease: a new possible biomarker
of acute coronary syndrome [J]. Int J Immunopathol Pharma?
col, 2011,24(4):905-913.
[20] 刘浩,武刚.早发冠心病急性心肌梗死的危险因素及临床特点分
析[J].中国全科医学,2012,15(11):1205-1208.